Previous Article | Next Article 
Infection and Immunity, October 2000, p. 5603-5609, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Interleukin-4 (IL-4) and IL-13 Signaling Pathways Do Not Regulate
Borrelia burgdorferi-Induced Arthritis in Mice: IgG1 Is Not
Required for Host Control of Tissue Spirochetes
Melissa R.
Potter,1
Nancy
Noben-Trauth,2
John H.
Weis,1
Cory
Teuscher,3 and
Janis
J.
Weis1,*
Department of Pathology, University of Utah
School of Medicine, Salt Lake City, Utah 841321;
Laboratory of Immunology, National Institute of Allergy and
Infectious Diseases, National Institutes of Health, Bethesda,
Maryland 20892-18922; and Department of
Veterinary Pathobiology, University of Illinois at
Urbana-Champaign, Urbana, Illinois 618023
Received 6 April 2000/Returned for modification 8 June
2000/Accepted 30 June 2000
 |
ABSTRACT |
Previous studies have suggested that interleukin-4 (IL-4) has a
protective effect in host defense to Borrelia burgdorferi infection, both in limiting the severity of arthritis and in
controlling spirochete numbers in tissues, and a mapping study revealed
suggestive linkage to a cluster of genes on mouse chromosome 11, including the genes for IL-4 and IL-13. In contrast, other studies have questioned the importance of IL-4. In this study the involvement of
IL-4 in murine Lyme disease was examined in C57BL/6J and BALB/cJ mice
with targeted disruptions in the IL-4 gene, the IL-4R
chain gene, or both. A spectrum of arthritis severity was seen in BALB/cJ mice, and ablation of IL-4, IL-4R
, or both had no effect on the overall severity of arthritis as determined by joint swelling and
histopathology. Wild-type C57BL/6J mice exhibited mild to moderate
arthritis, and ablation of IL-4 again had no effect on arthritis
severity. IL-4- and IL-4R
-deficient mice produced extremely low
levels of immunoglobulin G1 (IgG1) and showed increased production of
IgG2b. This shift in immunoglobulin isotype had no effect on the host's ability to control spirochete growth in either strain of
mouse, as determined by PCR detection of B. burgdorferi DNA from heart and ankle tissues. In summary, the IL-4-IL-4R
pathway, including IL-13 signaling, neither limits arthritis severity nor is
required for control of spirochete growth during B. burgdorferi infection of mice. Furthermore, the IgG1 isotype is
not required to control B. burgdorferi cell numbers in
tissues. These findings suggest the host defense against B. burgdorferi infection is not dependent on the Th1-Th2 paradigm of
T-cell responses.
 |
INTRODUCTION |
Lyme disease is a tick-transmitted
infection caused by the spirochete Borrelia burgdorferi
(17, 25, 42). Illness in humans can be successfully treated
with antibiotics; however, in the absence of treatment, arthritis,
carditis, neurological complications, and skin abnormalities may
develop (42). Arthritis is a late-stage symptom in
approximately 60% of individuals who are not treated with antibiotics
at the time of infection. The arthritis is associated with the presence
of spirochetes in the joint tissue and is characterized by tendonitis,
synovitis, and inflammatory cell infiltrate (41, 42).
The mouse model of Lyme disease has provided an opportunity to
study the development of arthritis upon infection with B. burgdorferi. In mice, arthritis is coincident with spirochetes in
the joint tissues and is characterized by tendonitis, synovial
hyperproliferation, and infiltration of neutrophils (7).
There is a spectrum of disease with different mouse strains having
differing susceptibilities to B. burgdorferi-induced
pathology. Infected C3H mice develop severe arthritis with large
numbers of bacteria infiltrating joint tissue (8, 12, 52).
C57BL/6 mice predominantly develop mild arthritis and yet harbor large
numbers of spirochetes that equal those in C3H mice (8, 10,
30). BALB/c mice show a spectrum of disease severity. At low
inoculum doses, BALB/c mice develop mild arthritis which becomes more
severe as the inoculum dose is increased (30). It appears
that there may be more than one mechanism of resistance, since
resistance in BALB/c mice correlates with low levels of spirochetes in
the joints, while in C57BL/6 mice arthritis is mild even in the
presence of large numbers of spirochetes (30).
A mapping project has been carried out in this laboratory using the
F2 intercross generation of C3H/HeNCr and C57BL/6NCr mice (51). Four chromosomal regions were linked to arthritis
development by quantitative trait loci (QTL) analysis, confirming that
arthritis development is a complex, multigenic trait with multiple
mechanisms. Interestingly, ankle swelling and histopathological
severity were linked to distinct chromosomal regions in this study. An
additional suggestive quantitative trait locus for histopathology was
identified in a region of chromosome 11 that contains a cluster of
immune and inflammatory regulatory cytokines, including interleukin-3 (IL-3), IL-4, IL-5, and IL-13. This cluster of genes is associated with
the regulation of Th cell responses, regulating T-cell and inflammatory
responses to infection (22).
Previous studies provide conflicting evidence regarding the involvement
of IL-4 in Lyme arthritis. Antibody (Ab)-mediated depletion of IL-4 in
BALB/c and C3H mice suggested a protective effect for IL-4 (29,
33), as did experiments in which treatment of C3H/HeN mice with
recombinant IL-4 reduced arthritis severity (28). Others
have shown that the kinetics of IL-4 production differs in severe and
mildly arthritic mice (27). However, in BALB/c mice,
interruption of the B7/CD28 costimulatory pathway using an Ab to CD86
prevented T-cell production of IL-4, yet it had no effect on arthritis
development (48). Most recently, arthritis-resistant DBA
mice that were genetically deficient in IL-4 did not show increased
arthritis severity when infected with B. burgdorferi
(14). These conflicting results suggest that the regulation,
production, and action of IL-4 during B. burgdorferi infection may be more complex than could be examined in previous experiments.
In response to conflicting results in the literature and the suggestive
linkage from our mapping study, we have chosen to look at the effects
of IL-4 production in Lyme disease by using mice that are genetically
altered to prevent the expression of IL-4, the
chain of the IL-4
receptor, or both. These mice enabled us to examine the involvement of
IL-4 in the development of Lyme arthritis, regardless of the cell type
producing it, location of its production, site of action, or responsive
cell type. In other pathogen systems, it has been found that IL-13
signaling through the IL-4R
chain can compensate for the absence of
IL-4, because the two cytokines have many of the same effects (20, 24, 39, 49). Therefore, the IL-4R
knockout with disruption of
both IL-4 and IL-13 signaling allowed us to determine whether IL-13
plays a role in the severity of Lyme arthritis and/or is able to
compensate for a loss of IL-4 during infection.
 |
MATERIALS AND METHODS |
Mice.
Male and female C3H/HeN mice were obtained from the
National Cancer Institute. Male and female C3H/HeJ, BALB/cJ,
BALB/cJ-Il-4tm2Nnt, C57BL/6J, and
C57BL/6J-Il-4tm1Nnt mice were obtained from the
Jackson Laboratories (Bar Harbor, Maine).
BALB/cJ-IL-4R
/
mice were generated as previously
described (40). BALB/cJ-IL-4
/
IL-4R
/
mice were obtained by an intercross between
BALB/cJ-IL-4
/
and BALB/cJ-IL-4R
/
mice. The designation C3H is used when data have been pooled, including
for experiments performed with both C3H/HeJ and C3H/HeN mice. Mice were
housed in the Animal Resource Center at the University of Utah Medical
Center, according to the National Institutes of Health guidelines for
care and use of laboratory animals.
Bacteria and infection.
Mice between 4 and 6 weeks of age
were infected by intradermal injection in the shaven back with 2 × 103 bacteria of the N40 isolate of B. burgdorferi (provided by S. Barthold, University of California at
Davis, at passage 3 from an infected mouse) (8), a mode of
infection reported to require the fewest spirochetes and to most
closely mimic tick transmission (6, 43). In one experiment,
mice from 10 to 13 weeks of age were used, with results similar to
those for mice 4 to 6 weeks of age. Passage 4 spirochetes were grown in
BSK-H medium containing 6% rabbit serum (Sigma, St. Louis, Mo.) for 3 to 5 days prior to injection, enumerated using a Petroff-Hauser
chamber, and diluted with sterile medium. Mock-infected animals
received intradermal injection of sterile BSK-H medium in the shaven
back and tested negative for B. burgdorferi infection by
both PCR and serology.
Measurement of ankle joints.
Rear ankle joints of mice
anesthetized with methoxyflurane (Pitman-Moore) were measured with a
metric caliper (Mitutoyo, Tokyo, Japan) during each week of infection.
Measurements were taken in the anterior-to-posterior position, with the
ankle extended, through the thickest portion of the ankle. Numerous
factors can influence normal joint measurements, including age, sex,
and strain of mice; therefore, findings are reported as the change in
joint measurement relative to that of mock-infected matched animals.
Histopathology of ankle joints.
The rear ankle joint
displaying the greatest swelling at the time of sacrifice was taken
from each mouse for histological analysis. Samples were fixed in 10%
formalin, decalcified, and embedded in paraffin, and sections were
stained with hematoxylin and eosin. Sections were viewed in a blind
fashion and given a score for severity ranging from 0 to 4+, as
previously described (30).
Preparation of DNA from infected tissues.
Mice were
sacrificed at 4 weeks postinfection, and rear ankle joint and heart
tissues were prepared as previously described (47). Briefly,
tissue specimens were incubated in 0.1% collagenase A (Boehringer
Mannheim) solution at 37°C overnight and were then mixed with an
equal volume of proteinase K solution (Boehringer Mannheim) and
incubated at 55°C overnight. DNA was then recovered by extraction
with an equal volume of phenol-chloroform and precipitated with
ethanol. After digestion with 1 mg of DNase-free RNase (Sigma) per ml
the samples were extracted again, and DNA was recovered by
precipitation. The precipitated DNA was resuspended in 1 to 1.5 ml of
water, and the DNA content was determined by measuring the absorbance
at 260 nm.
Quantification of DNA from infected tissues.
The levels of
B. burgdorferi DNA in joints and hearts were determined by
continuous-monitoring PCR, using the LightCycler (Idaho Technologies,
Idaho Falls, Idaho) as previously described (36). Briefly,
200 ng of sample DNA was amplified in a final volume of 10 µl
containing 50 mM Tris (pH 8.3), 3 mM MgCl2, 4.5 µg of
bovine serum albumin, 200 µM deoxynucleoside triphosphates, a
1:30,000 dilution of SYBER Green I (Molecular Probes, Eugene, Oreg.), 5 µM each primer, 0.5 U of Taq polymerase (GIBCO BRL, Gaithersburg, Md.), and 110 ng of TaqStart Ab (ClonTech, Palo Alto,
Calif.). Forty cycles of amplification were performed, with each cycle
consisting of three steps: heating at 20°C/s to 95°C with a 1-s
hold, cooling at 20°C/s to 60°C with a 1-s hold, and heating at
1°C/s to 84°C. This technique monitors the cycle-by-cycle accumulation of fluorescently labeled product. The cycle at which the
product is first detected was an indicator of relative starting copy
number and was calculated by using the LightCycler analysis software.
B. burgdorferi was quantified by using the
chromosomally encoded recA gene, and values were normalized
to 104 copies of a single-copy mouse gene, nidogen. The
oligonucleotide primers used to detect mouse nidogen were nido.F
(5'-CCA GCC ACA GAA TAC CAT CC-3') and nido.R (5'-GGA
CAT ACT CTG CTG CCA TC-3'). The oligonucleotide primers used to
detect B. burgdorferi recA were nTM 17.F (5'-GTG GAT
CTA TTG TAT TAG ATG AGG CTC TCG-3') and nTM17.R (5'-GCC AAA
GTT CTG CAA CAT TAA CAC CTA AAG-3').
Detection of B. burgdorferi-specific immunoglobulin
(Ig) levels.
Serum obtained by retro-orbital bleeding of
experimental animals at sacrifice was analyzed for B. burgdorferi-specific Ab using an Ab capture ELISA. Eleven columns
per 96-well plate were coated with B. burgdorferi sonicate
at a concentration of 5 µg of sonicate/ml. The 12th column was coated
with polyclonal rabbit anti-mouse immunoglobulin G (IgG) plus IgA plus
IgM (Zymed, South San Francisco, Calif.) at a concentration of 5 µg/ml. Serum samples were added to B. burgdorferi
sonicate-coated wells and analyzed for isotype-specific Ab content at
the following dilutions: IgG1 at a dilution of 1:100, IgG2a at 1:500,
IgG2b at 1:1,000, and IgG3 at 1:1,000. Known concentrations of IgG1,
IgG2a, IgG2b, and IgG3 were added to the rabbit anti-mouse Ig wells to
ensure that results were within the linear range. Following a 2-h
incubation with serum samples, unbound sample was removed by washing,
and the anti-B. burgdorferi Ab was detected by the addition
of alkaline phosphatase-conjugated rabbit anti-mouse IgG1, IgG2a,
IgG2b, or IgG3 (Zymed), respectively, for 1 h. Plates were washed
and developed by incubation with 1 mg of p-nitrophenyl
phosphate per ml in Tris buffer (Sigma) for 30 min, stopped with 3 N
NaOH, and read at 405 nm on a 96-well microtest plate spectrophotometer
(Molecular Devices). Values are expressed as the optical density at 405 nm (OD405).
Statistical analysis.
The degrees of statistical
significance of the quantitative differences between sample groups were
determined by application of Student's t test.
 |
RESULTS |
Effect of genetic ablation of IL-4 and the IL-4R
chain on
B. burgdorferi-induced arthritis severity in
BALB/cJ and C57BL/6J mice.
BALB/cJ mice deficient in
IL-4 or the IL-4R
chain were developed through gene targeting in a
BALB/cJ embryonic stem cell, an approach that ensures a pure background
on which to examine the roles of IL-4 and IL-4R
(38, 40).
Wild-type C3H mice and BALB/cJ mice of these genotypes
[wild type, IL-4
/
IL-4R
/
,
IL-4-IL-4R
/
and IL-4R+/
] were each
infected with 2,000 B. burgdorferi cells intradermally in
the shaven back. This dose of B. burgdorferi was expected to cause mild to moderate arthritis in wild-type BALB/cJ mice and severe
disease in C3H mice (8, 12, 30, 52).
Arthritis severity was assessed by examining the change in rear-ankle
joint measurements compared to those of control animals. Joints
were measured weekly, with measurements at week 4 postinfection being maximal (data not shown). Throughout four experiments, the wild-type BALB/cJ mice showed a range of joint swelling from mild to
severe, while C3H mice showed moderate to severe swelling (Fig. 1). The absence of IL-4, IL-4R
, or
both had no affect on joint swelling, as the range of measurements seen
was consistent with that of the wild-type BALB/cJ mice. The variability
of arthritis severity in BALB/cJ mice made it necessary to perform
several experiments to determine whether a reproducible effect was
observed. While individual experiments might suggest that mice of one
genotype had more severe arthritis than wild-type mice, by combining
the results of four experiments, we concluded there was not a
consistent difference in arthritis severity relative to that of mice of
the IL-4 or IL-4R genotype.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
Effect of IL-4 and IL-4R ablation on ankle swelling
in B. burgdorferi-infected BALB/cJ mice. Mice were infected
with 2,000 B. burgdorferi cells, and joints were measured at
4 weeks postinfection as described in Materials and Methods. Open
circles, values for joints with the greatest swelling from each mouse;
black bars, average values for the group. The number of mice in each
group is represented below the strain name. Results are combined from
four individual experiments. The difference in joint swelling between
infected mice on the BALB/cJ background and C3H mice was statistically
significant (P < 0.001). No statistical difference was
seen between mice on the BALB/cJ background.
|
|
A second IL-4-deficient mouse, created by gene targeting in a C57BL/6J
embryonic stem cell line, was also examined (
34).
The
C57BL/6N strain of mouse is resistant to severe arthritis
when infected
with
B. burgdorferi at very high infectious doses
(
8,
30). Although the C57BL/6J substrain occasionally displays
greater variability in arthritis severity than the C57BL/6N substrain,
it is consistently less severe than arthritis in C3H mice
(
16).
Mice were infected with 2,000 spirochetes, and the
course of infection
was monitored for 4 weeks. C3H/HeN mice showed
moderate to severe
joint swelling throughout the 4-week course of
infection, while
the wild-type C57BL/6J mice had mild to moderate
swelling (Fig
2.). The IL-4-deficient
C57BL/6J mice showed mild to moderate
joint swelling, nearly identical
to that of the wild-type mice.

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 2.
Ankle swelling in IL-4-deficient C57BL/6J mice
throughout the 4-week course of infection. Mice were infected with
2,000 B. burgdorferi cells, and joints were measured as
described in Materials and Methods. Data points represent the averages
and bars indicate the standard deviations of values for five to seven
infected animals.
|
|
Joint swelling and histopathological assessments of arthritis severity
are regulated by distinct genetic regions; therefore,
we also assessed
histopathology (
51). One joint from each animal
was taken at
sacrifice for histological analysis and examined
for arthritis
severity. C3H mice had severe arthritis scores (2+
to 4+), while the
wild-type BALB/cJ mice showed a range of mild
to severe scores (1+ to
4+), with an overall severity slightly
less than that seen in C3H mice
(Table
1). The IL-4- and
IL-4R

-deficient
mice showed a range of severity that was not
significantly different
from that of wild-type BALB/cJ mice. A dosage
effect was not seen
in the BALB/cJ IL-4R
+/
mice, because
in these mice arthritis severity did not differ
significantly from that
of wild-type mice (Fig.
1; Table
1).
Arthritis severity was mild to
moderate in wild-type C57BL/6J
mice, and mice deficient in IL-4 showed
the same range of severity
as the wild-type animals. These data suggest
that IL-4 plays neither
a protective nor an antagonistic role in
the development of arthritis
during
B. burgdorferi
infection in the BALB/cJ and C57BL/6J strains.
Further, IL-13
signaling through the IL-4R

chain does not appear
to be important
for the regulation of arthritis severity or to
compensate for a lack of
IL-4 signaling on the BALB/cJ background.
Spirochete numbers in the joint and heart tissues of animals
lacking IL-4 or the IL-4R
chain.
Although IL-4 does not appear
to play a role in regulating arthritis severity, it may be involved in
the control of B. burgdorferi numbers. In previous
experiments, animals which had been treated with an IL-4 Ab yielded
higher numbers of spirochetes following culture for several days,
suggesting that IL-4 is involved in the control of spirochete numbers
(29). To more directly address the numbers of B. burgdorferi in tissues, we performed continuously monitored PCR on
DNA collected from tissues at 4 weeks postinfection. Previously, using
a different PCR technology, we had shown that, at an inoculum dose of
2,000 B. burgdorferi cells, 5- to 10-fold fewer spirochetes
persist in the joint and heart tissues of BALB/cAn than of C3H/HeJ mice
(30). In this study, with a newly developed PCR method,
fivefold fewer spirochetes were found in the joints of wild-type
BALB/cJ mice than of C3H/HeN mice (Fig.
3A). A similar three to fivefold
difference in spirochete numbers was seen between the IL-4- and
IL-4R
-deficient mice and the C3H/HeN mice. Spirochete numbers
were threefold higher in the hearts of C3H/HeN mice than in
those of the wild-type, IL-4-, or IL-4R
-deficient BALB/cJ mice
(Fig. 3B). Overall, deficiency in IL-4 or IL-4R
had no effect on
spirochete numbers in tissues from BALB/cJ mice.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 3.
B. burgdorferi numbers in joint (A) and heart
(B) tissues of IL-4- and IL-4R -deficient mice on the BALB/cJ
background. Mice were infected with 2,000 B. burgdorferi
cells, and tissues were harvested at 4 weeks postinfection. DNA was
isolated from tissues and assessed using continuously monitored PCR.
Circles, amounts of B. burgdorferi-specific DNA present in
individual mouse tissues relative to genomic mouse DNA. Black lines,
average values for the animals in each group (n 6 in each group). Uninfected controls were negative for B. burgdorferi. These results are representative of four separate
experiments. The difference in B. burgdorferi
numbers between infected mice on the BALB/cJ background and C3H mice
was statistically significant (P 0.025 for joints
and P 0.04 for hearts [two-tailed t
test]).
|
|
C57BL/6N mice are resistant to severe arthritis when infected with
B. burgdorferi; however, the levels of spirochetes
persisting
in their joints are approximately equal to those
found in C3H/HeN
mice (
30). In contrast, C57BL/6N mice have
very few spirochetes
in their hearts compared to the number in C3H/HeN
mice (
30).
Continuous-monitoring PCR analysis revealed
nearly equivalent
numbers of spirochetes in the joints of C57BL/6J
and C3H/HeN mice
(Fig.
4A). The
IL-4-deficient C57BL/6J mice showed a slightly
larger range of
spirochete numbers in the joints; however, the
differences in the
numbers of spirochetes present were not significant.
Hearts from the
C3H/HeN mice contained fivefold more spirochetes
than those
of either the wild-type or IL-4-deficient C57BL/6 mice.
The lack of
difference in spirochete numbers between any of the
IL-4- or
IL-4R

-deficient mice and their wild-type controls demonstrated
that
IL-4 signaling and IL-13 signaling through the IL-4R

chain
are not
required for control of spirochete numbers in joints and
hearts.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
B. burgdorferi numbers in joint (A)
and heart (B) tissues from IL-4-deficient animals on the C57BL/6J
background. Mice were infected with 2,000 B. burgdorferi
cells, and tissues were harvested at 4 weeks postinfection. DNA was
isolated from tissues and assessed using continuously monitored PCR.
Circles, amounts of B. burgdorferi-specific DNA present in
individual mouse tissues relative to genomic mouse DNA; black bars,
average values for the animals in each group (n 4 in
each group). Uninfected controls were negative for B. burgdorferi. The difference in B. burgdorferi numbers
in heart tissues, between infected mice on the C57BL/6J background and
C3H mice, was statistically significant (P 0.001 [two-tailed t test]).
|
|
Immunoglobulin isotype profiles in mice lacking IL-4 and
IL-4R
.
Passive immunization of naive mice with serum from
animals infected with B. burgdorferi prior to infection has
been shown to be effective in preventing infection (9, 11).
The importance of antibodies for resolution of Lyme disease has also
been confirmed in studies using immune-compromised scid- and
rag-deficient mice, which are unable to resolve infection
(13, 15, 45, 46). It has not directly been shown that any
single isotype of Ab is more effective at clearing B. burgdorferi or influencing the development of severe arthritis.
However, it has been inferred from the reported effects of IL-4
depletion that Th2-dependent isotype IgG1 could be more effective than
other isotypes at clearing B. burgdorferi (29,
33). Because IL-4 induces class switching to IgG1, we determined
by ELISA the relative levels of various IgG isotypes in mice infected
with 2,000 B. burgdorferi cells. Table
2 shows a comparison of the relative
amounts of Ab produced by wild-type C3H and BALB/cJ mice, as well as
the IL-4- and IL-4R
-deficient mice on the BALB/cJ background.
It is quite interesting that the C3H mice produced greater
quantities of all Ab isotypes than the wild-type BALB/cJ mice did. The
IL-4- and IL-4R
-deficient mice had barely detectable levels of IgG1,
which were greatly reduced compared to levels in the wild-type BALB/cJ
mice. IL-4- and IL-4R
-deficient mice produced increased amounts of
IgG2b. IgG2a and IgG3 levels showed little variation between mice of
the BALB/cJ background.
Differences in Ab production were also assessed on the C57BL/6J
background (Table
3). The amounts of
IgG2a produced were
not determined in these mice because C57BL/6 mice
do not possess
the gene for Ig-
2a, but instead they
possess a novel Ig-
2c gene,
which is not recognized by
commercial antibodies to IgG2 (
26,
31,
32). Wild-type
C57BL/6J mice produced only a small amount
of IgG1 antibody, barely
detectable above background, as did the
C57BL/6 IL-4-deficient mice. As
was seen previously, in the IL-4-
and IL-4R

-deficient mice on the
BALB/cJ background, IL-4-deficient
C57BL/6J mice produced greater
amounts of IgG2b and similar levels
of IgG3 Ab compared to levels in
the wild-type mice. Although
there were alterations in the amounts and
isotypes of Abs produced
in the IL-4- and IL-4R

-deficient mice,
these differences did
not correlate with changes in arthritis severity
or
B. burgdorferi numbers during the first 4 weeks of
infection.
 |
DISCUSSION |
In this study, we examined the effects of genetic ablation of IL-4
and the IL-4R
chain in order to determine the roles that IL-4 and
IL-13 play in host defense against B. burgdorferi
infection. IL-4 has previously been shown to play a role in
resistance to severe arthritis, and its presence correlated with
decreased joint swelling during infection (28, 29,
33). Throughout the study we saw variability in the severity of
arthritis in BALB/cJ wild-type mice. By doing several experiments, we
were able to conclude that the absence of IL-4 or the IL-4R
chain
did not lead to more severe arthritis or joint swelling when wild-type
mice had mild arthritis or to less severe arthritis and joint
swelling when wild-type mice had severe arthritis. This conclusion
points out the care that must be exercised in using the dose-responsive
BALB/c mice and may explain why others using BALB/c mice previously
reported a greater effect for IL-4 (28, 29, 33). The results
of experiments with mice on the C57BL/6J background were quite clear,
showing no differences in arthritis severity or joint swelling between IL-4-deficient and wild-type mice. Our results show that IL-4 and IL-13
are not required for resistance to arthritis upon infection with
B. burgdorferi. These results are consistent with the
findings for another IL-4-deficient mouse on the resistant DBA
background (14).
The role of IL-4 in the host response to B. burgdorferi
infection has previously been addressed in the context of Th1 versus Th2 responses in the mouse. A Th1 response including gamma interferon production and isotype switching to IgG2a was suggested to be detrimental to the host, leading to the development of severe arthritis
and the inability to control spirochete numbers (28, 29,
33). IL-4 production, as part of a Th2 response, and isotype switching to IgG1 were believed to be crucial for resistance to severe
arthritis and control of spirochete numbers (28, 29, 33).
Surprisingly, our experiments show that arthritis-susceptible C3H
mice make Borrelia-specific Abs of all isotypes
IgG1,
IgG2a, IgG2b, and IgG3, in larger amounts than those of
either of the resistant BALB/cJ or C57BL/6J strains. Although
C3H mice are able to produce IgG1 in amounts equivalent to those of
BALB/cJ mice, they still harbor fivefold more bacteria in their joints.
IL-4- and IL-4R
-deficient BALB/cJ mice produce almost no IgG1, yet they are able to control spirochete numbers in both joint and heart
tissues, suggesting that IgG1 is not required for host control of
spirochete numbers. Interestingly, all of the IL-4- and
IL-4R
-deficient mice produced more IgG2b than did their wild-type
counterparts; however, this change had no effect on spirochete numbers.
The C57BL/6J mice that were deficient in IL-4 retained similar
bacterial numbers in joints and hearts compared to those retained by
wild-type C57BL/6J mice. Overall, the absence of IL-4 and IL-4
receptor signaling had no effect on spirochete presence in tissues;
therefore, these cytokines do not appear to be necessary for host
control of B. burgdorferi during the first 4 weeks of infection.
A recent study addressed the role of IL-4 in B. burgdorferi
infection by using an IL-4-deficient mouse on the DBA background (14). The results presented here confirm and expand on those results by looking at additional mouse strains, as well as examining B. burgdorferi infection in a mouse lacking the IL-4R
chain. IL-4 and IL-13 share the IL-4R
chain as a common component in their receptor complexes (1, 21, 23, 35), leading to many
similar downstream effects (18, 37, 53). For example, granuloma formation in Schistosoma mansoni-infected mice
lacking IL-4 was found to be dependent on IL-13 and disappeared when
IL-4R
/
mice were infected (19, 20, 24, 34, 44,
49, 50). Through the use of an IL-4R
-deficient mouse, the
present study has shown that IL-4 is not required for resistance to the
development of severe arthritis or for control of bacterial numbers in
the joint and heart tissues and that, in BALB/cJ mice, IL-13 is not compensating for the absence of IL-4.
Genes encoding IL-4 and IL-13 can now be eliminated as candidate genes
for the region of chromosome 11 with suggestive linkage to arthritis
severity (51). Experiments have now shown that the absence
of IL-4 on the resistant DBA (14), C57BL/6J, and BALB/cJ
backgrounds or the absence of the IL-4R
chain on the BALB/cJ
background has no effect on arthritis severity. Although IL-4 and IL-13
are not required for resistance to severe arthritis, production of the
inflammatory molecules IL-6, IL-11, and IL-12 appears to regulate the
host response to B. burgdorferi infection (2-5).
Furthermore, the absence of the anti-inflammatory cytokine IL-10 on the
C57BL/6 background leads to increased arthritis severity in a resistant
mouse strain (16). These results suggest that the balance of
pro- and antiinflammatory molecules may be involved in regulating Lyme
arthritis severity, but at a level other than the production of IL-4 or
through the IL-4-IL-13 signaling pathway.
 |
ACKNOWLEDGMENTS |
This work was supported by National Institutes of Health grants
AI-32223 (J.J.W.) and AR-43521 (J.J.W and C.T.) and grant 5P30-CA-42014
to the University of Utah. The project described was also supported in
part by an award from the American Lung Association (J.H.W.). M.R.P.
was supported as a predoctoral trainee by National Institutes of Health
Genetics training grant 5T32 GM07464.
We thank the NIAID Care Unit for their technical support.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: University of
Utah School of Medicine, Department of Pathology, 50 North Medical
Drive, Salt Lake City, UT 84132. Phone: (801) 581-8386. Fax: (801)
581-4517. E-mail: janis.weis{at}path.med.utah.edu.
Editor:
J. D. Clements
 |
REFERENCES |
| 1.
|
Aman, M. J.,
N. Tayebi,
N. I. Obiri,
R. K. Puri,
W. S. Modi, and W. J. Leonard.
1996.
cDNA cloning and characterization of the human interleukin 13 receptor alpha chain.
J. Biol. Chem.
271:29265-29270[Abstract/Free Full Text].
|
| 2.
|
Anguita, J.,
S. W. Barthold,
S. Samanta,
J. Ryan, and E. Fikrig.
1999.
Selective anti-inflammatory action of interleukin-11 in murine Lyme disease: arthritis decreases while carditis persists.
J. Infect. Dis.
179:734-737[CrossRef][Medline].
|
| 3.
|
Anguita, J.,
D. H. Persing,
M. Rincon,
S. W. Barthold, and E. Fikrig.
1996.
Effect of anti-interleukin 12 treatment on murine lyme borreliosis.
J. Clin. Investig.
97:1028-1034[Medline].
|
| 4.
|
Anguita, J.,
M. Rincon,
S. Samanta,
S. W. Barthold,
R. A. Flavell, and E. Fikrig.
1998.
Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis.
J. Infect. Dis.
178:1512-1515[CrossRef][Medline].
|
| 5.
|
Anguita, J.,
S. Samanta,
S. W. Barthold, and E. Fikrig.
1997.
Ablation of interleukin-12 exacerbates Lyme arthritis in SCID mice.
Infect. Immun.
65:4334-4336[Abstract].
|
| 6.
|
Barthold, S. W.
1991.
Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice.
J. Infect. Dis.
163:419-420[Medline].
|
| 7.
|
Barthold, S. W.
1996.
Lyme borreliosis in the laboratory mouse.
J. Spirochet. Tick-Borne Dis.
3:22-44.
|
| 8.
|
Barthold, S. W.,
D. S. Beck,
G. M. Hansen,
G. A. Terwilliger, and K. D. Moody.
1990.
Lyme borreliosis in selected strains and ages of laboratory mice.
J. Infect. Dis.
162:133-138[Medline].
|
| 9.
|
Barthold, S. W., and L. K. Bockenstedt.
1993.
Passive immunizing activity of sera from mice infected with Borrelia burgdorferi.
Infect. Immun.
61:4696-4702[Abstract/Free Full Text].
|
| 10.
|
Barthold, S. W., and M. de Souza.
1995.
Exacerbation of Lyme arthritis in beige mice.
J. Infect. Dis.
172:778-784[Medline].
|
| 11.
|
Barthold, S. W.,
S. Feng,
L. K. Bockenstedt,
E. Fikrig, and K. Feen.
1997.
Protective and arthritis-resolving activity in sera of mice inspected with Borrelia burgdorferi.
Clin. Infect. Dis.
25(Suppl. 1):S9-S17.
|
| 12.
|
Barthold, S. W.,
D. H. Persing,
A. L. Armstrong, and R. A. Peeples.
1991.
Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice.
Am. J. Pathol.
139:263-273[Abstract].
|
| 13.
|
Barthold, S. W.,
C. L. Sidman, and A. L. Smith.
1992.
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency.
Am. J. Trop. Med. Hyg.
47:605-613.
|
| 14.
|
Brown, C. R., and S. L. Reiner.
1999.
Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.
Infect. Immun.
67:3329-3333[Abstract/Free Full Text].
|
| 15.
|
Brown, C. R., and S. L. Reiner.
1999.
Genetic control of experimental Lyme arthritis in the absence of specific immunity.
Infect. Immun.
67:1967-1973[Abstract/Free Full Text].
|
| 16.
|
Brown, J. P.,
J. F. Zachary,
C. Teuscher,
J. J. Weis, and R. M. Wooten.
1999.
Dual role of interleukin-10 in murine lyme disease: regulation of arthritis severity and host defense.
Infect. Immun.
67:5142-5150[Abstract/Free Full Text].
|
| 17.
|
Burgdorfer, W.,
A. G. Barbour,
S. F. Hayes,
J. L. Benach,
E. Grunwaldt, and J. P. Davis.
1982.
Lyme disease: a tick-borne spirochetosis?
Science
216:1317-1319[Abstract/Free Full Text].
|
| 18.
|
Callard, R. E.,
D. J. Matthews, and L. Hibbert.
1996.
IL-4 and IL-13 receptors: are they one and the same?
Immunol. Today
17:108-110[CrossRef][Medline].
|
| 19.
|
Cheever, A. W.,
M. E. Williams,
T. A. Wynn,
F. D. Finkelman,
R. A. Seder,
T. M. Cox,
S. Hieny,
P. Caspar, and A. Sher.
1994.
Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis.
J. Immunol.
153:753-759[Abstract].
|
| 20.
|
Chiaramonte, M. G.,
L. R. Schopf,
T. Y. Neben,
A. W. Cheever,
D. D. Donaldson, and T. A. Wynn.
1999.
IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs.
J. Immunol.
162:920-930[Abstract/Free Full Text].
|
| 21.
|
Gauchat, J. F.,
E. Schlagenhauf,
N. P. Feng,
R. Moser,
M. Yamage,
P. Jeannin,
S. Alouani,
G. Elson,
L. D. Notarangelo,
T. Wells,
H. P. Eugster, and J. Y. Bonnefoy.
1997.
A novel 4-kb interleukin-13 receptor alpha mRNA expressed in human B, T, and endothelial cells encoding an alternate type-II interleukin-4/interleukin-13 receptor.
Eur. J. Immunol.
27:971-978[Medline].
|
| 22.
|
Gorham, J. D.,
M. L. Guler,
R. G. Steen,
A. J. Mackey,
M. J. Daly,
K. Frederick,
W. F. Dietrich, and K. M. Murphy.
1996.
Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses.
Proc. Natl. Acad. Sci. USA
93:12467-12472[Abstract/Free Full Text].
|
| 23.
|
Hilton, D. J.,
J. G. Zhang,
D. Metcalf,
W. S. Alexander,
N. A. Nicola, and T. A. Willson.
1996.
Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor.
Proc. Natl. Acad. Sci. USA
93:497-501[Abstract/Free Full Text].
|
| 24.
|
Jankovic, D.,
M. C. Kullberg,
N. Noben-Trauth,
P. Caspar,
J. M. Ward,
A. W. Cheever,
W. E. Paul, and A. Sher.
1999.
Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile.
J. Immunol.
163:337-342[Abstract/Free Full Text].
|
| 25.
|
Johnson, R. C.,
G. P. Schmid,
F. W. Hyde,
A. G. Steigwalt, and D. J. Brenner.
1984.
Borrelia burgdorferi sp. nov.: etiologic agent of Lyme disease.
Int. J. Syst. Bacteriol.
34:496-497.
|
| 26.
|
Jouvin-Marche, E.,
M. G. Morgado,
C. Leguern,
D. Voegtle,
F. Bonhomme, and P. A. Cazenave.
1989.
The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes.
Immunogenetics
29:92-97[CrossRef][Medline].
|
| 27.
|
Kang, I.,
S. W. Barthold,
D. H. Persing, and L. K. Bockenstedt.
1997.
T-helper-cell cytokines in the early evolution of murine Lyme arthritis.
Infect. Immun.
65:3107-3111[Abstract].
|
| 28.
|
Keane-Myers, A.,
C. R. Maliszewski,
F. D. Finkelman, and S. P. Nickell.
1996.
Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice.
J. Immunol.
156:2488-2494[Abstract].
|
| 29.
|
Keane-Myers, A., and S. P. Nickell.
1995.
Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice.
J. Immunol.
155:2020-2028[Abstract].
|
| 30.
|
Ma, Y.,
K. P. Seiler,
E. J. Eichwald,
J. H. Weis,
C. Teuscher, and J. J. Weis.
1998.
Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice.
Infect. Immun.
66:161-168[Abstract/Free Full Text].
|
| 31.
|
Martin, R. M., and A. M. Lew.
1998.
Is IgG2a a good Th1 marker in mice?
Immunol. Today
19:49[Medline].
|
| 32.
|
Martin, R. M.,
A. Silva, and A. M. Lew.
1997.
The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype.
Immunogenetics
46:167-168[CrossRef][Medline].
|
| 33.
|
Matyniak, J. E., and S. L. Reiner.
1995.
T helper phenotype and genetic susceptibility in experimental Lyme disease.
J. Exp. Med.
181:1251-1254[Abstract/Free Full Text].
|
| 34.
|
Metwali, A.,
D. Elliott,
A. M. Blum,
J. Li,
M. Sandor,
R. Lynch,
N. Noben-Trauth, and J. V. Weinstock.
1996.
The granulomatous response in murine Schistosomiasis mansoni does not switch to Th 1 in IL-4-deficient C57BL/6 mice.
J. Immunol.
157:4546-4553[Abstract].
|
| 35.
|
Miloux, B.,
P. Laurent,
O. Bonnin,
J. Lupker,
D. Caput,
N. Vita, and P. Ferrara.
1997.
Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex.
FEBS Lett.
401:163-166[CrossRef][Medline].
|
| 36.
|
Morrison, T. B.,
Y. Ma,
J. H. Weis, and J. J. Weis.
1999.
Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR.
J. Clin. Microbiol.
37:987-992[Abstract/Free Full Text].
|
| 37.
|
Murata, T.,
J. Taguchi,
R. K. Puri, and H. Mohri.
1999.
Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Int. J. Hematol.
69:13-20[Medline].
|
| 38.
|
Noben-Trauth, N.,
G. Kohler,
K. Burki, and B. Ledermann.
1996.
Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.
Transgenic Res.
5:487-491[CrossRef][Medline].
|
| 39.
|
Noben-Trauth, N.,
W. E. Paul, and D. L. Sacks.
1999.
IL-4- and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains.
J. Immunol.
162:6132-6140[Abstract/Free Full Text].
|
| 40.
|
Noben-Trauth, N.,
L. D. Shultz,
F. Brombacher,
J. F. Urban, Jr.,
H. Gu, and W. E. Paul.
1997.
An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice.
Proc. Natl. Acad. Sci. USA
94:10838-10843[Abstract/Free Full Text].
|
| 41.
|
Nocton, J. J.,
F. Dressler,
B. J. Rutledge,
P. N. Rys,
D. H. Persing, and A. C. Steere.
1994.
Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis.
N. Engl. J. Med.
330:229-234[Abstract/Free Full Text].
|
| 42.
|
Nocton, J. J., and A. C. Steere.
1995.
Lyme disease.
Adv. Intern. Med.
40:69-117[Medline].
|
| 43.
|
Pachner, A. R.,
E. Delaney, and N. S. Ricalton.
1992.
Murine Lyme borreliosis: route of inoculation determines immune response and infectivity.
Reg. Immunol.
4:345-351[Medline].
|
| 44.
|
Pearce, E. J.,
A. Cheever,
S. Leonard,
M. Covalesky,
R. Fernandez-Botran,
G. Kohler, and M. Kopf.
1996.
Schistosoma mansoni in IL-4-deficient mice.
Int. Immunol.
8:435-444[Abstract/Free Full Text].
|
| 45.
|
Schaible, U. E.,
S. Gay,
C. Museteanu,
M. D. Kramer,
G. Zimmer,
K. Eichmann,
U. Museteanu, and M. M. Simon.
1990.
Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.
Am. J. Pathol.
137:811-820[Abstract].
|
| 46.
|
Schaible, U. E.,
R. Wallich,
M. D. Kramer,
G. Nerz,
T. Stehle,
C. Museteanu, and M. M. Simon.
1994.
Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.
Int. Immunol.
6:671-681[Abstract/Free Full Text].
|
| 47.
|
Seiler, K. P.,
Z. Vavrin,
E. Eichwald,
J. Hibbs, Jr., and J. J. Weis.
1995.
Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.
Infect. Immun.
63:3886-3895[Abstract].
|
| 48.
|
Shanafelt, M. C.,
I. Kang,
S. W. Barthold, and L. K. Bockenstedt.
1998.
Modulation of murine Lyme borreliosis by interruption of the B7/CD28 T- cell costimulatory pathway.
Infect. Immun.
66:266-271[Abstract/Free Full Text].
|
| 49.
|
Urban, J. F., Jr.,
N. Noben-Trauth,
D. D. Donaldson,
K. B. Madden,
S. C. Morris,
M. Collins, and F. D. Finkelman.
1998.
IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis.
Immunity
8:255-264[CrossRef][Medline].
|
| 50.
|
Warren, K. S.,
E. O. Domingo, and R. B. Cowan.
1967.
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity.
Am. J. Pathol.
51:735-756[Medline].
|
| 51.
|
Weis, J. J.,
B. A. McCracken,
Y. Ma,
D. Fairbairn,
R. J. Roper,
T. B. Morrison,
J. H. Weis,
J. F. Zachary,
R. W. Doerge, and C. Teuscher.
1999.
Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease.
J. Immunol.
162:948-956[Abstract/Free Full Text].
|
| 52.
|
Yang, L.,
J. H. Weis,
E. Eichwald,
C. P. Kolbert,
D. H. Persing, and J. J. Weis.
1994.
Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues.
Infect. Immun.
62:492-500[Abstract/Free Full Text].
|
| 53.
|
Zurawski, G., and J. E. de Vries.
1994.
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells.
Immunol. Today
15:19-26[CrossRef][Medline].
|
Infection and Immunity, October 2000, p. 5603-5609, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Tupin, E., Benhnia, M. R.-E.-I., Kinjo, Y., Patsey, R., Lena, C. J., Haller, M. C., Caimano, M. J., Imamura, M., Wong, C.-H., Crotty, S., Radolf, J. D., Sellati, T. J., Kronenberg, M.
(2008). NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi. Proc. Natl. Acad. Sci. USA
105: 19863-19868
[Abstract]
[Full Text]
-
Nardelli, D. T., Callister, S. M., Schell, R. F.
(2008). Lyme Arthritis: Current Concepts and a Change in Paradigm. CVI
15: 21-34
[Full Text]
-
Lazarus, J. J., Meadows, M. J., Lintner, R. E., Wooten, R. M.
(2006). IL-10 Deficiency Promotes Increased Borrelia burgdorferi Clearance Predominantly through Enhanced Innate Immune Responses. J. Immunol.
177: 7076-7085
[Abstract]
[Full Text]
-
Wang, X., Ma, Y., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2005). Relative Contributions of Innate and Acquired Host Responses to Bacterial Control and Arthritis Development in Lyme Disease. Infect. Immun.
73: 657-660
[Abstract]
[Full Text]
-
Brown, C. R., Blaho, V. A., Loiacono, C. M.
(2003). Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2. J. Immunol.
171: 893-901
[Abstract]
[Full Text]
-
Wooten, R. M., Ma, Y., Yoder, R. A., Brown, J. P., Weis, J. H., Zachary, J. F., Kirschning, C. J., Weis, J. J.
(2002). Toll-Like Receptor 2 Is Required for Innate, But Not Acquired, Host Defense to Borrelia burgdorferi. J. Immunol.
168: 348-355
[Abstract]
[Full Text]
-
Wang, G., Ojaimi, C., Iyer, R., Saksenberg, V., McClain, S. A., Wormser, G. P., Schwartz, I.
(2001). Impact of Genotypic Variation of Borrelia burgdorferi Sensu Stricto on Kinetics of Dissemination and Severity of Disease in C3H/HeJ Mice. Infect. Immun.
69: 4303-4312
[Abstract]
[Full Text]